ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
1-Year Return
24.45%
This Quarter Return
+6.42%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$4.21B
AUM Growth
+$290M
(+7.4%)
Cap. Flow
+$44.3M
Cap. Flow
% of AUM
1.05%
Top 10 Holdings %
Top 10 Hldgs %
19.84%
Holding
1,462
New
252
Increased
614
Reduced
435
Closed
141
Top Buys
| 1 |
NVIDIA
NVDA
|
+$37.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$30.2M |
| 3 |
Verizon
VZ
|
+$29.5M |
| 4 |
Microsoft
MSFT
|
+$21.8M |
| 5 |
Gilead Sciences
GILD
|
+$19.8M |
Top Sells
| 1 |
Tesla
TSLA
|
+$19.4M |
| 2 |
AbbVie
ABBV
|
+$19.1M |
| 3 |
Johnson & Johnson
JNJ
|
+$17.8M |
| 4 |
ServiceNow
NOW
|
+$15.8M |
| 5 |
Roblox
RBLX
|
+$13.4M |
Sector Composition
| 1 | Technology | 21.58% |
| 2 | Energy | 13.05% |
| 3 | Healthcare | 8.58% |
| 4 | Financials | 8.4% |
| 5 | Communication Services | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Sun Communities
SUI
$16.1B
| $175K | ﹤0.01% |
1,292
+1,052
| +438% | +$142K |
|
1002
Geron
GERN
$823M
| $174K | ﹤0.01% |
38,321
-85,861
| -69% | -$390K |
|
1003
Cincinnati Financial
CINF
$23.8B
| $174K | ﹤0.01% |
+1,275
| New | +$174K |
|
1004
Repare Therapeutics
RPTX
$75.6M
| $174K | ﹤0.01% |
50,441
+8,809
| +21% | +$30.3K |
|
1005
Zimmer Biomet
ZBH
$20.3B
| $173K | ﹤0.01% |
1,603
+1,552
| +3,043% | +$168K |
|
1006
Albemarle
ALB
$8.63B
| $172K | ﹤0.01% |
1,817
+444
| +32% | +$42.1K |
|
1007
Day One Biopharmaceuticals
DAWN
$744M
| $171K | ﹤0.01% |
12,286
-3,031
| -20% | -$42.2K |
|
1008
Southern Copper
SCCO
$82.9B
| $171K | ﹤0.01% |
1,527
-4,647
| -75% | -$520K |
|
1009
Revolution Medicines
RVMD
$7.56B
| $171K | ﹤0.01% |
3,760
-3,037
| -45% | -$138K |
|
1010
Allogene Therapeutics
ALLO
$246M
| $170K | ﹤0.01% |
60,675
+12,328
| +25% | +$34.5K |
|
1011
Y-mAbs Therapeutics
YMAB
$390M
| $169K | ﹤0.01% |
12,872
-1,617
| -11% | -$21.3K |
|
1012
Foghorn Therapeutics
FHTX
$291M
| $168K | ﹤0.01% |
18,085
-17,836
| -50% | -$166K |
|
1013
Zymeworks
ZYME
$1.15B
| $168K | ﹤0.01% |
13,386
-6,794
| -34% | -$85.3K |
|
1014
Zentalis Pharmaceuticals
ZNTL
$105M
| $167K | ﹤0.01% |
45,506
+30,098
| +195% | +$111K |
|
1015
Merus
MRUS
$5.08B
| $167K | ﹤0.01% |
3,336
-1,537
| -32% | -$76.8K |
|
1016
Recursion Pharmaceuticals
RXRX
$1.98B
| $166K | ﹤0.01% |
25,182
+5,021
| +25% | +$33.1K |
|
1017
Cullinan Oncology
CGEM
$382M
| $166K | ﹤0.01% |
9,891
-2,961
| -23% | -$49.6K |
|
1018
Ventas
VTR
$31.5B
| $165K | ﹤0.01% |
2,577
+2,484
| +2,671% | +$159K |
|
|
TSVT
1019
DELISTED
2seventy bio
TSVT
| $164K | ﹤0.01% |
34,816
-20,064
| -37% | -$94.7K |
|
1020
Arvinas
ARVN
$575M
| $164K | ﹤0.01% |
6,659
+1,798
| +37% | +$44.3K |
|
1021
Expedia Group
EXPE
$26.7B
| $164K | ﹤0.01% |
1,105
+1,029
| +1,354% | +$152K |
|
1022
Kymera Therapeutics
KYMR
$3.11B
| $163K | ﹤0.01% |
3,454
-2,048
| -37% | -$96.9K |
|
1023
Invesco S&P 500 Equal Weight ETF
RSP
$74.2B
| $163K | ﹤0.01% |
+912
| New | +$163K |
|
1024
iShares Gold Trust Micro
IAUM
$3.74B
| $163K | ﹤0.01% |
6,213
+808
| +15% | +$21.2K |
|
1025
iShares Gold Trust
IAU
$53.5B
| $163K | ﹤0.01% |
+3,281
| New | +$163K |
|